274 related articles for article (PubMed ID: 27062182)
1. Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis.
Raffetti E; Fattovich G; Donato F
Liver Int; 2016 Sep; 36(9):1239-51. PubMed ID: 27062182
[TBL] [Abstract][Full Text] [Related]
2. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
3. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
[TBL] [Abstract][Full Text] [Related]
4. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
[TBL] [Abstract][Full Text] [Related]
5. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
[TBL] [Abstract][Full Text] [Related]
6. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
7. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ;
Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
[TBL] [Abstract][Full Text] [Related]
9. Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy.
Ieluzzi D; Covolo L; Donato F; Fattovich G
Dig Liver Dis; 2014 May; 46(5):427-32. PubMed ID: 24548819
[TBL] [Abstract][Full Text] [Related]
10. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.
Brechot C; Kremsdorf D; Soussan P; Pineau P; Dejean A; Paterlini-Brechot P; Tiollais P
Pathol Biol (Paris); 2010 Aug; 58(4):278-87. PubMed ID: 20667665
[TBL] [Abstract][Full Text] [Related]
12. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
Iloeje UH; Yang HI; Chen CJ
Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification for hepatitis B virus related hepatocellular carcinoma.
Lin CL; Kao JH
J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus.
Osawa M; Akuta N; Suzuki F; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Suzuki Y; Ikeda K; Kumada H
J Med Virol; 2017 Dec; 89(12):2144-2148. PubMed ID: 28667756
[TBL] [Abstract][Full Text] [Related]
15. Perspectives and control of hepatitis B virus infection in Taiwan.
Lin CL; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
[TBL] [Abstract][Full Text] [Related]
16. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
[TBL] [Abstract][Full Text] [Related]
17. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS
J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252
[TBL] [Abstract][Full Text] [Related]
18. East Asia expert opinion on treatment initiation for chronic hepatitis B.
Kao JH; Hu TH; Jia J; Kurosaki M; Lim YS; Lin HC; Sinn DH; Tanaka Y; Wai-Sun Wong V; Yuen MF
Aliment Pharmacol Ther; 2020 Nov; 52(10):1540-1550. PubMed ID: 32951256
[TBL] [Abstract][Full Text] [Related]
19. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
[TBL] [Abstract][Full Text] [Related]
20. Development of hepatocellular carcinoma in chronic hepatitis B patients with advanced fibrosis is independent of viral genotype.
Kumar R; Testoni B; Fresquet J; Lim TK; Hao Y; Tan HH; Chow WC; Zoulim F
J Med Virol; 2017 May; 89(5):845-848. PubMed ID: 27709629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
